{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:15Z","timestamp":1793307975503,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.acra.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:57:47Z","timestamp":1751011067000},"page":"6739-6750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transarterial Radioembolization with Yttrium-90 and SIRT Versus Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Jo\u00e3o Pedro Toledo Lima","family":"de Alc\u00e2ntara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Willian Xavier da Rosa","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acra.2025.06.008_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.acra.2025.06.008_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.acra.2025.06.008_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.008_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.acra.2025.06.008_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"10.1016\/j.acra.2025.06.008_bib6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.acra.2025.06.008_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1016\/j.acra.2025.06.008_bib8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.acra.2025.06.008_bib9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00270-016-1426-y","article-title":"Unresectable hepatocellular carcinoma: radioembolization versus chemoembolization: a systematic review and meta-analysis","volume":"39","author":"Lobo","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"18","key":"10.1016\/j.acra.2025.06.008_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4254\/wjh.v8.i18.770","article-title":"Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a\u00a0systematic review and meta-analysis","volume":"8","author":"Facciorusso","year":"2016","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.acra.2025.06.008_bib11","first-page":"641","article-title":"TRACE trial: a\u00a0randomized controlled trial comparing transarterial radioembolization with yttrium-90 glass microspheres versus conventional transarterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"77","author":"Dhondt","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.acra.2025.06.008_bib12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews and meta-analyses","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.acra.2025.06.008_bib13","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.acra.2025.06.008_bib14","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.acra.2025.06.008_bib15","year":"2020"},{"key":"10.1016\/j.acra.2025.06.008_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.acra.2025.06.008_bib17","first-page":"944","article-title":"Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma","volume":"61","author":"Auer","year":"2020","journal-title":"Acta Radiol"},{"issue":"6","key":"10.1016\/j.acra.2025.06.008_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5152\/dir.2021.201089","article-title":"The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi method expert panel in Turkey","volume":"27","author":"Akarca","year":"2021","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"10.1016\/j.acra.2025.06.008_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40001-022-00708-w","article-title":"Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?","volume":"27","author":"Benk\u00f6","year":"2022","journal-title":"Eur J Med Res"},{"issue":"7","key":"10.1016\/j.acra.2025.06.008_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jvir.2014.04.014","article-title":"Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"25","author":"Rostambeigi","year":"2014","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.008_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00270-014-1012-0","article-title":"Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma","volume":"38","author":"Pitton","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.acra.2025.06.008_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/03007995.2024.2322057","article-title":"Real-world evidence of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases","volume":"40","author":"Cook","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.acra.2025.06.008_bib23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvir.2016.03.046","article-title":"Yttrium-90 radioembolization as a salvage treatment following chemoembolization for hepatocellular carcinoma","volume":"27","author":"Johnson","year":"2016","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.acra.2025.06.008_bib24","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.acra.2023.10.029","article-title":"Objective tumor response of hepatocellular carcinoma obtained by transarterial radioembolization with iodine-131-lipiodol versus transarterial chemoembolization for patients with and without portal venous thrombosis: a controlled interventional trial","volume":"31","author":"Ribeiro","year":"2024","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.008_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1602709","article-title":"Transarterial chemoembolization and radioembolization across barcelona clinic liver cancer stages","volume":"34","author":"Titano","year":"2017","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.acra.2025.06.008_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fradi.2024.1346550","article-title":"Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization","volume":"4","author":"Wagenpfeil","year":"2024","journal-title":"Front Radiol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.008_bib27","first-page":"269","article-title":"Safety and efficacy of transarterial radioembolization combined with chemoembolization for bilobar hepatocellular carcinoma: a single-center retrospective study","volume":"41","author":"Kwon","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.acra.2025.06.008_bib28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MEG.0000000000001625","article-title":"Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study","volume":"32","author":"Jeliazkova","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.acra.2025.06.008_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental Yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study","volume":"28","author":"Padia","year":"2017","journal-title":"J Vasc Interv Radiol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225005549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225005549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T21:05:09Z","timestamp":1763327109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225005549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1076633225005549"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.06.008","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial Radioembolization with Yttrium-90 and SIRT Versus Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}